PSC 833 blocker of the multiple drug resistance pump in cancer cells: Update

Novartis AG, Basel, Switzerland
Product: PSC 833

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE